Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance

SIMPLE SUMMARY: Despite years of molecular discoveries and technological advances in surgery, the prognosis of glioblastoma (GBM) still remains unfavorable, with a mean overall survival typically less than 20 months. Recurrence of tumors, and specifically of GBM, could be due to the persistence of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Agosti, Edoardo, Panciani, Pier Paolo, Zeppieri, Marco, De Maria, Lucio, Pasqualetti, Francesco, Tel, Alessandro, Zanin, Luca, Fontanella, Marco Maria, Ius, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215375/
https://www.ncbi.nlm.nih.gov/pubmed/37237548
http://dx.doi.org/10.3390/biology12050736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215375/
https://www.ncbi.nlm.nih.gov/pubmed/37237548
http://dx.doi.org/10.3390/biology12050736

Ejemplares similares